摘要
目的 研究高危型人乳头瘤病毒(HPV)感染的型别、载量与宫颈癌及癌前病变的相关性。方法 采用双色荧光定量PCR方法对307例宫颈组织细胞样本进行8种高危型HPVDNA(主要高危型:HPV16,18,45,31和次要高危型HPV33,52,58,67)分型及病毒载量检测。结果 307例样本HPVDNA与液基细胞学(LCT)检测结果均是阴性236例,两者均为阳性34例;62例HPVDNA阳性结果中LCT阴性28例、宫颈炎26例以及宫颈上皮肉瘤样病变(CIN)I~Ⅲ8例,245例HPVDNA阴性结果中LCT阳性9例;LCT阴性者感染HPV主要表现为次要高危型(15/28)与HPV16(12/28)感染,宫颈炎感染HPV主要表现为次要高危型HPV(17/26)、HPV16及HPV16伴随其它型别的多重感染(6/26)和HPV31(4/26)感染,不同型别HPV感染,感染的HPV病毒载量均≥102copies/cell。LCT阴性者与富颈癌前病变患者(宫颈炎、CINⅠ~Ⅲ)之间HPV感染率差异有显著性(P〈0.05),而病毒载量差异无显著性(P〉0.05)。结论 HPV16与HPV次要高危型感染是宫颈炎与宫颈癌前病变的主要诱因,高危型HPV病毒载量与宫颈癌前病变无明显相关性。
Objective To study the relationship between the types and viral load of human papilloma virus(HPV) infection and cervical precancerous lesions. Methods Adopting two-channels real time PCR to genotype and quantify eight high risk HPV DNA in 307 cervical epithelia samples (high risk types:HPV16,18,45,31;intermediate risk types .. HPV33, 52 , 58 , 67). Results Using respectively real time PCR and LCT to test the 307 samples,both negative results are 236;both positive results are 34. 28 negative result of liquid based thin prepcytologytest (LCT), 26 cervicitis and 8 cervical intraepithelial neoplasias(CIN) ⅦⅠ~Ⅲ are detected in 62 HPV DNA positive samples. 9 LCT positive are detected in 245 HPV DNA negative samples. The types of HPV are mainly intermediate risk (15/28) and 16 (12/28) in positive HPV samples while they are negative for LCT. The mainly HPV types in cervicitis are intermediate risk types (17/26) ,HPV 16 or associated with other types (6/26) and HPV31 (4/26). The viral loads of HPV infection are all ≥10^2copies/cell among all type of HPV. There is a statistically significant difference in HPV infection rate between the LCT negative patients and the precancerous lesions patients (cervicitis, CIN Ⅰ~Ⅲ) (P〈0.05). However,there is no statistically significant difference in viral load (P〉0.05). Conclusion The main causes of cervicitis and precancerous lesions are the infection of HPV16 and intermediate-high risk types (HPV33/52/58/67). There is no statistically significant difference in viral load between high risk types and precancerous lesions.
出处
《现代检验医学杂志》
CAS
2007年第4期32-35,共4页
Journal of Modern Laboratory Medicine